Inconsistent Immunohistochemical Expression Patterns of Four Different CD133 Antibody Clones in Glioblastoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inconsistent Immunohistochemical Expression Patterns of Four Different CD133 Antibody Clones in Glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Volume 59, Issue 4, Pages 391-407
Publisher
SAGE Publications
Online
2011-05-24
DOI
10.1369/0022155411400867
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
- (2010) K. Kemper et al. CANCER RESEARCH
- Marker-independent identification of glioma-initiating cells
- (2010) Virginie Clément et al. NATURE METHODS
- Immunohistochemical Expression of Stem Cell, Endothelial Cell, and Chemosensitivity Markers in Primary Glioma Spheroids Cultured in Serum-Containing and Serum-Free Medium
- (2010) Karina Christensen et al. NEUROSURGERY
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
- (2009) Myung Jin Son et al. Cell Stem Cell
- Limits of CD133 as a marker of glioma self-renewing cells
- (2009) Virginie Clément et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of the Value of Frozen Tissue Section Used as “Gold Standard” for Immunohistochemistry
- (2008) Shan-Rong Shi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
- (2008) Heike Immervoll et al. BMC CANCER
- CD133 Expression and Cancer Stem Cells Predict Prognosis in High-grade Oligodendroglial Tumors
- (2008) Dagmar Beier et al. BRAIN PATHOLOGY
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
- (2008) R. Pallini et al. CLINICAL CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Prostate Cancer Stem Cells: A New Target for Therapy
- (2008) Norman J. Maitland et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
- (2008) Scott Bidlingmaier et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CD133 identifies perivascular niches in grade II–IV astrocytomas
- (2008) Karina Christensen et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
- (2008) Kyeung Min Joo et al. LABORATORY INVESTIGATION
- Presence of pluripotent CD133+ cells correlates with malignancy of gliomas
- (2008) Niklas Thon et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma
- (2008) Qin Shu et al. STEM CELLS
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Brain micro-ecologies: neural stem cell niches in the adult mammalian brain
- (2007) P. A Riquelme et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started